Patent Assignment
Reel/Frame 042243/0830
Change of Name
Recorded: 2017-05-04
Pages: 2
Assignor
QLT INC.
Executed: 2016-11-29
Assignee
NOVELION THERAPEUTICS INC.
887 GREAT NORTHERN WAY, SUITE 101, VANCOUVER, B.C., V5T 4T5, CANADA
Covered Property
(1)
Pharmaceutical Formulations Comprising 9-Cis-Retinyl Esters in a Lipid Vehicle
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 4, 2017
From: BOCH, RONALD ERWIN
To: QLT INC.
Reel/Frame 042243/0666 →
Assignment of Assignor's Interest
Feb 21, 2019
From: NOVELION THERAPEUTICS INC.
To: RETINAGENIX, LLC
Reel/Frame 048403/0004 →
Assignment of Assignor's Interest
Mar 20, 2020
From: RETINAGENIX, LLC
To: RETINAGENIX THERAPEUTICS, INC.
Reel/Frame 052175/0176 →
Assignment of Assignor's Interest
Apr 7, 2021
From: RETINAGENIX THERAPEUTICS, INC.
To: RETINAGENIX HOLDINGS LLC
Reel/Frame 055857/0001 →
Assignment of Assignor's Interest
Aug 9, 2022
From: RETINAGENIX HOLDINGS LLC
To: ELUMINEX BIOSCIENCES (SUZHOU) LIMITED
Reel/Frame 060763/0001 →